The results show highest levels of nuclear HspBP1 in normal tissues and then progressively lower levels in human breast cancer tissues with increasing cancer grades (Fig. 8A, B), suggesting that nuclear HspBP1 expression correlates negatively with advancing clinical stages of breast tumors. Here, HSPBP1 is linked to breast neoplasm.